Benzinga | Oct 29, 2020 07:39AM EDT

Evelo Biosciences Q3 EPS $(0.45) Beats $(0.50) Estimate

Evelo Biosciences (NASDAQ:EVLO) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(0.50) by 10 percent. This is a 32.84 percent increase over losses of $(0.67) per share from the same period last year.